The most common molecular genetic abnormalities in cytogenetically normal AML are Fms related tyrosine kinase receptor 3 (FLT3), nucleophosmin 1 (NPM1) and tet methylcytosine dioxygenase 2 (TET2) mutations [3]. This evidence concerns the gene FLT3 and acute myeloid leukemia.